Legal status (US): Ipamorelin is not FDA-approved for any human indication
Heinemeier KM, Mackey AL, Doessing S, Hansen M, Bayer ML, Nielsen RH, et al
It is the simultaneous drift of dozens of biological systems away from their optimal states over decades
Consequently, the newly revealed combined NO-system background (i.e., common therapy effect, common NO-response) [59,70] might, for BPC 157 therapy, particularly allocate matching positive-like and negative-like symptoms or indicate specific circuits between the involved brain areas, mesolimbic pathways in the positive-like symptoms and fronto-cortical temporal and cortico-striatal pathways in the negative-like symptoms [1]
10.1016/j.arr.2015.01.001 18 LiH.LowY
the Austrian Infrastructure Program 2016/2017